These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 22231914)
1. Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al. Graudal N; Jürgens G Arthritis Rheum; 2012 Apr; 64(4):1297-8; author reply 1298-9. PubMed ID: 22231914 [No Abstract] [Full Text] [Related]
2. In early rheumatoid arthritis the combination of methotrexate and infliximab over 2 years reduces the progression of radiological lesions more than methotrexate alone. Montecucco C Clin Exp Rheumatol; 2005; 23(3):289-291. PubMed ID: 15971414 [No Abstract] [Full Text] [Related]
3. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al. Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353 [No Abstract] [Full Text] [Related]
4. Treatment of rheumatoid arthritis: we are getting there. Yazici Y Lancet; 2009 Jul; 374(9685):178-80. PubMed ID: 19560809 [No Abstract] [Full Text] [Related]
5. Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. Knudsen LS; Ostergaard M; Baslund B; Narvestad E; Petersen J; Nielsen HJ; Ejbjerg BJ; Szkudlarek M; Johansen JS Scand J Rheumatol; 2006; 35(6):489-91. PubMed ID: 17343261 [No Abstract] [Full Text] [Related]
6. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug. Rau R; Wassenberg S J Rheumatol; 1999 Oct; 26(10):2280-1. PubMed ID: 10529157 [No Abstract] [Full Text] [Related]
7. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al. Yazici Y; Yazici H Arthritis Rheum; 2006 Sep; 54(9):3061-2. PubMed ID: 16948140 [No Abstract] [Full Text] [Related]
8. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al. Francis S; Block MJ Arthritis Rheum; 2010 Sep; 62(9):2826; author reply 2826-8. PubMed ID: 20556822 [No Abstract] [Full Text] [Related]
9. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN; N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166 [TBL] [Abstract][Full Text] [Related]
10. Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et al. Seitz M; Villiger PM Arthritis Rheum; 2003 Mar; 48(3):863. PubMed ID: 12632454 [No Abstract] [Full Text] [Related]
11. Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extension. Keystone EC; Genovese MC; Hall S; Miranda PC; Bae SC; Palmer W; Wu Z; Xu S; Hsia EC J Rheumatol; 2013 Jul; 40(7):1097-103. PubMed ID: 23678153 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs in rheumatoid arthritis: results of the GO-MORE study in Spain. Alonso A; González CM; Ballina J; García Vivar ML; Gómez-Reino JJ; Marenco JL; Fernández-Nebro A; Ordás C; Cea-Calvo L; Arteaga MJ; Sanmartí R Reumatol Clin; 2015; 11(3):144-50. PubMed ID: 25022442 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate and radiographic disease progression in patients with rheumatoid arthritis. Kremer JM J Rheumatol; 1999 Feb; 26(2):241-3. PubMed ID: 9972951 [No Abstract] [Full Text] [Related]
14. Radiographic progression in early rheumatoid arthritis: comment on the article by Goronzy et al. Sanmarti R; Gómez-Centeno A; Gratacós J; Cañete JD Arthritis Rheum; 2004 Sep; 50(9):3052-3; author reply 3053-4. PubMed ID: 15457481 [No Abstract] [Full Text] [Related]
15. Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study. van Vollenhoven RF; Cifaldi MA; Ray S; Chen N; Weisman MH Arthritis Care Res (Hoboken); 2010 Feb; 62(2):226-34. PubMed ID: 20191522 [TBL] [Abstract][Full Text] [Related]
16. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial. Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU; Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810 [TBL] [Abstract][Full Text] [Related]
17. Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al. Kirwan JR Arthritis Rheum; 1999 May; 42(5):1066-7. PubMed ID: 10323469 [No Abstract] [Full Text] [Related]
18. Reconsideration of the effects of methotrexate therapy on radiographic progression in rheumatoid arthritis: comment on the article by Weinblatt et al. Roces A; Cantabrana A; Hayek M; Dávila M Arthritis Rheum; 1994 Jul; 37(7):1114. PubMed ID: 8024623 [No Abstract] [Full Text] [Related]
19. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al. Morgan SL; Baggott JE; Alarcón GS Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062 [No Abstract] [Full Text] [Related]
20. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC Int J Rheum Dis; 2016 Nov; 19(11):1143-1156. PubMed ID: 26259617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]